Sagimet Biosciences Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | — | $2.0 | — | — |
| Operating income | -$56.9 | -$54.5 | -$30.7 | -$31.1 | — |
| Net income | -$51.0 | -$45.6 | -$27.9 | -$30.5 | — |
Shares outstanding 61.8M · Free float 70.4%
Annual filing data through FY ended December 31, 2025; float as of August 26, 2026.